• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights of People with ALS/MND and Caregivers
    • Research
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Development
      • AB Science – Masitinib
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Radicava/Edaravone
      • Neudexta
      • Riluzole/Tiglutik
  • Support for Health Professionals
    • How to Break the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Student Award Nomination
      • Forbes Norris Award Nomination
      • Humanitarian Award Nomination
      • Allied Health Professional Award Nomination
  • Members
    • Member Registration
    • Forgot Password

Awards

The International Alliance of ALS/MND Associations presents four awards to recognize excellence in the ALS/MND community. The awards are described below, along with a list of previous winners.

Student Award

The Alliance has created a new Student Award to be presented for the first time at the 2023 Alliance Conference. The purpose of this award is to encourage ALS/MND exposure and awareness in the global student community, provide a platform for students to showcase their innovative ideas that would improve the quality of life of people living with ALS/MND, and drive innovation within the ALS/MND space.

The criteria for the Student award are that the nominee must; have initiated and implemented work that will have an international impact on people living with ALS/MND; explored new and innovative ideas for improving quality of life of PALS that shows an understanding of PALS needs; have potential to be an achievable and accessible solution; and, must be a full-time student.

The Forbes Norris Award

The Forbes Norris Award, first presented in 1994, honours the memory of Dr. Forbes “Ted” Norris (1928-1993), a neurologist who dedicated his career to helping people with ALS/MND. The purpose of this prestigious award is to encourage a combination of two major qualities: management of and advances in understanding ALS/MND, to the benefit of people living with the disease. The criteria for the Forbes Norris award are that the nominee must be; a major participant in the delivery of outstanding ALS/MND patient care; a significant contributor to the medical literature on ALS/MND clinical management or basic science; and a member of team/s undertaking ongoing research into ALS/MND care, management and/or basic science.

Nominations for the Forbes Norris Award are considered annually; the awards are presented each year during the opening ceremony of the International Symposium on ALS/MND.  If there are no qualified candidates nominated in a particular year, the award will not be granted.

2022 Forbes Norris Award Recipient

The International Alliance of ALS/MND Associations is proud to recognize American Professor of Neurology Dr. Richard Bedlack with the 2022 Forbes Norris Award. This distinguished award honours his decades-long contribution to the management of and advances in understanding ALS/MND.

Dr. Bedlack operates from the belief that everyone living with ALS/MND should receive the highest quality of care possible. It is with this philosophy in mind that he created and directs the Duke ALS Clinic in the US. By adhering to best practices, he offers families the resources of a large interdisciplinary care team, presenting all available treatment options, so they are able to approach the disease in the way that is best for them.

Leading and participating in research initiatives that create a better understanding of and better treatments for ALS/MND is integral to Dr. Bedlack’s approach to patient care. Through his involvement in multi-centre trials, investigator-initiated studies and research, he has established himself as a leader in the field. From innovative study models to the training of Research Ambassadors through the NEALS Clinical Research Learning Institute, Dr. Bedlack has been on the forefront of advocacy and education initiatives to expand research opportunities and increase trial participation, with the goal of creating a world free of ALS/MND.

One of his most notable public contributions is the creation of the ALSUntangled™ website. A tremendous resource to the ALS/MND community, it provides scientific reviews of alternative and off label treatments to help people make informed decisions about their care.

“What began with seeing his first person with ALS/MND and a desire to ‘do better’ has led to a 20-year career of striving to continuously offer better care and treatments for those living with ALS/MND,” says his colleague Stacey Asnani. “During this time, Dr. Bedlack has built a world-class ALS clinic, made significant contributions to clinical research, and engaged in advocacy that has advanced initiatives leading to positive changes in care provision, education, benefits and research.”

Dr. Bedlack truly embodies the term “patient care” through the empathy, compassion and commitment he displays with every patient he sees. His unwavering dedication to the ALS/MND cause is apparent in every facet of his work, making him an inspiration to everyone affected by this disease across the globe.

Previous Winners

2021 Dr. Adriano Chiò

2020 Professor Ammar Al Chalabi

2018 Dr. Angela Genge

2017 Dr. Merit Cudkowicz

2016 Dr. Mamede de Carvalho

2015 Dr. Terry Heiman-Patterson

2014 Dr. Matthew Kiernan

2013 Dr. Leonard van den Berg

2012 Dr. Benjamin Brooks

2011 Professor Orla Hardiman

2010 Dr. Edward Kasarskis

2009 Professor Christopher Shaw

2008 Dr. Michael Strong

2007 Dame Professor Pamela Shaw

2006 Dr. Walter G. Bradley

2005 Dr. Stanley Appel

2004 Dr. Robert G. Miller

2003 Dr. Robert H. Brown

2002 Professor Vianney DeJong

2001 Dr. Lewis P. (Bud) Rowland

2000 Professor Michael Swash

1999 Dr. Andrew Eisen

1998 Dr. Hiroshi Mitsumoto

1997 Professor Nigel Leigh

1996 Dr. Donald Mulder

1995 Dr. Teepu Siddique

1994 Professor Vincent Meininger

 

The Humanitarian Award

The Humanitarian Award was inaugurated in 2000 by the International Alliance of ALS/MND Associations to recognise a non-scientific contribution to the fight against ALS/MND. The Humanitarian Award is intended to recognise and encourage individuals and/or groups whose work makes, or has made, a contribution of international significance for people affected by ALS/MND.

2022 Humanitarian Award Recipient

Sally Light, Chief Executive of the MND Association in England, Wales and Northern Ireland, has been awarded the 2022 Humanitarian Award from the International Alliance of ALS/MND Associations. This prestigious award honours Light’s leadership in raising awareness and action around ALS/MND.

When Light joined the MND Association in 2012, multidisciplinary care of people living with ALS/MND was inconsistent in many parts of the UK. Thanks to her extensive experience in neurological care management, she successfully led a campaign to establish a national clinical guideline for ALS/MND, which has ultimately improved the quality and consistency of care within the UK and influenced service provision globally. For instance, it led to the expansion of dedicated ALS/MND Care Centres and Networks in the UK, which form the backbone for national and international multicentre clinical research studies and therapeutic trials.

Light understands the need for greater international co-operation in research and care in all areas of work. During her tenure, the MND Association has invested in multinational programs such as the Project MinE genetic consortium and the ALS Reproducible Antibody Platform, and it is the formal patient association partner on the European Commission funded MIROCALS and TUDCA-ALS trials. It is also one of the largest research funders in the world, with over £16 million invested in 80 projects.

“Ms. Light has always put people with ALS/MND and their families at the centre of everything the Association has done and believed in the community that underpins and strengthens our cause,” explains Chris James of the MND Association. “She has championed greater empowerment of volunteers, a more participative membership, and continuous development of co-production and co-creation of our work and priorities. Despite the growth in size and complexity, she has never lost sight of whom we exist to support.”

“In everything she has done since she joined the Association 10 years ago, Ms. Light has shown total dedication to every aspect of our work in support of people living with and affected by ALS/MND,” adds Richard Coleman of the MND Association’s Board of Trustees. “Under her leadership, the Association has grown its revenue significantly, strengthened its advocacy on behalf of the ALS/MND community and increased its investment in research, which will enable us to attain our vision of a world free from ALS/MND.”

Previous Winners

2021 Dr. David Taylor

2020 Carol Birks

2019 Dario Ryba

2018 Dr. Brian Dickie

2017 Peter Frates, Patrick Quinn and Anthony Senerchia, Jr., the founders of the Ice Bucket Challenge.

2016 James Allen Heywood and Benjamin Heywood

2015 Jesus Mora

2014 Wendy Abrams

2013 Dr. Jeffrey Dietch

2012 Gudjon Sigurdsson

2011 Danny Reviers and Mia Mahy

2010 Jette Moeller

2009 Professor Kathy Mitchell

2008 Rodney Harris

2007 Tricia Holmes

2006 Mrs. Misao Hashimoto

2005 The MND Association of South Africa

2003 Dr. David Oliver

2002 Dee Holden Norris

2001 Yuko Matsuoka

2000 The MND Association of England, Wales and Northern Ireland

 

Allied Health Professional Award

The Allied Health Professional Award was inaugurated in 2018 by the International Alliance of ALS/MND Associations to; recognize an individual committed to providing exceptional care to people with ALS/MND; celebrate the sharing of expertise and exploration of new ideas to improve patient care; and to recognize significant contribution to the advancement of ALS/MND clinical management.

2022 Allied Professional Award Recipient

The International Alliance of ALS/MND Associations is pleased to announce Richard Cave as this year’s Allied Health Professional Award winner. He is being recognized for his work in the field of voice banking for people living with ALS/MND.

More than 80% of people living with ALS/MND develop difficulties with their speech, losing not only a functional means of communication but also a display of their individual and social identity through their vocal characteristics. Most of these people eventually use an augmentative and alternative communication device; however, the  synthesized voices of these devices are often viewed as impersonal and do not match the age or accent of the individual. Voice banking creates an approximation of the person’s own voice that can be used in these devices to help preserve their self-identity and perhaps even their dignity.

Richard Cave is a leader in the field of voice banking both in the UK and globally. In his role as speech language therapist with the MND Association in England, Wales and Northern Ireland, his participation was invaluable to the “I Will Always Be Me” project, where individuals across the world can bank their voice from the comfort of their own home. He has trained over 1,000 other therapists in the process of voice banking, has written and presented internationally on the subject, and regularly hosts free training sessions online. He also continues to personally help individuals living with ALS/MND who do not have access to a therapist or cannot voice bank by themselves record their voices each week.

Richard firmly believes people living with ALS/MND must be at the heart of decision making for new technological developments and focuses on bringing their lived experiences to everything he is involved in, such as Google’s many projects focused on helping people with non-standard speech be better understood by technology. He is also an active member of the International Alliance’s Innovation and Technology Advisory Council, which makes recommendations regarding technology and innovation strategies to benefit those living with and affected by ALS/MND globally.

“Richard is an international figurehead in the fight against ALS/MND,” says Nick Goldup of the MND Association. “He literally gives thousands of people living with ALS/MND a voice.”

Previous Winners

2021  Dr. Melinda Kavanaugh and Sarah Solomon

2020 John Costello

2019 Rachel Marsden

2018 Dr. Sara Feldman

Primary Sidebar

About

  • Who we are
  • Board of Directors
  • Committees/Advisory Councils
    • Scientific Advisory Council
    • PALS and CALS Advisory Council
    • Innovation and Technology Council
    • Governance Committee
    • Budget and Finance Committee
  • Staff
  • History
  • Archives
    • Newsletters
    • Meetings
  • Awards

  • Daniel Hare

    Daniel Hare

  • Joy Blakeley, Diagnosed 2017 - MND Australia

    Joy Blakeley, Diagnosed 2017 – MND Australia

  • Sanjay Kumar Srivastava, Asha Ek Hope Foundation for ALS/MND, Diagnosed 2018, India

    Sanjay Kumar Srivastava, Asha Ek Hope Foundation for ALS/MND, Diagnosed 2018, India

  • Carlos Gomez Matallanas, Diagnosed 2014 - FUNDELA, Spain

    Carlos Gomez Matallanas, Diagnosed 2014 – FUNDELA, Spain

  • Philip Brindle, MND Association, Diagnosed 2015, England

    Philip Brindle, MND Association, Diagnosed 2015, England

  • Osiel Mendoza, Diagnosed 2016 - ALS Therapy Development Institute, USA

    Osiel Mendoza, Diagnosed 2016 – ALS Therapy Development Institute, USA

  • Phil Rossall, MND-Association, UK

    Phil Rossall, MND-Association, UK

  • Juvenal Bayona Romero

    Juvenal Bayona Romero

  • Rolf Mauch, Association ALS Switzerland, Diagnosed 2015, Switzerland

    Rolf Mauch, Association ALS Switzerland, Diagnosed 2015, Switzerland

  • Soledad Rodriguez, FUNDELA, Diagnosed 2013, Spain

    Soledad Rodriguez, FUNDELA, Diagnosed 2013, Spain

  • Angie Bordaen, Diagnosed 2014 - ALS Liga België, Belgium

    Angie Bordaen, Diagnosed 2014 – ALS Liga België, Belgium

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Conny van der Meijden, Diagnosed 2001 - ALS Netherlands

    Conny van der Meijden, Diagnosed 2001 – ALS Netherlands

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Oliver Juenke, DGM, Germany

    Oliver Juenke, DGM, Germany

  • Eddy LeFrançois, Diagnosed 1992 - ALS Canada

    Eddy LeFrançois, Diagnosed 1992 – ALS Canada

  • Erwin Coppejans, Diagnosed 2007 - ALS Liga België, Belgium

    Erwin Coppejans, Diagnosed 2007 – ALS Liga België, Belgium

  • Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014, Switzerland

    Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014, Switzerland

  • Ailsa Malcolm-Hutton, Diagnosed 2013 - MND Association of England, Wales and N Ireland

    Ailsa Malcolm-Hutton, Diagnosed 2013 – MND Association of England, Wales and N Ireland

  • Glen Elison, ALS Hope Foundation, Diagnosed 2019, USA

    Glen Elison, ALS Hope Foundation, Diagnosed 2019, USA

  • Karl Hughes, Diagnosed 2010 - IMNDA, Ireland

    Karl Hughes, Diagnosed 2010 – IMNDA, Ireland

  • Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

    Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

  • Jon Newsome, Les Turner ALS Foundation, USA

    Jon Newsome, Les Turner ALS Foundation, USA

  • Frank "Papa" Taylor

    Frank “Papa” Taylor

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Ian Roberts

    Ian Roberts

  • Christian Bär, Germany

    Christian Bär, Germany

  • Jack Buzby, USA

    Jack Buzby, USA

  • Charlie “Hark” Dourney, Diagnosed 2007 - Hark ALS, USA

    Charlie “Hark” Dourney, Diagnosed 2007 – Hark ALS, USA

  • Elkin Ramiro Gaviria Muñoz, Diagnosed  December 2018

    Elkin Ramiro Gaviria Muñoz, Diagnosed December 2018

  • Fabio Carvalho

    Fabio Carvalho

  • Roxana Canova, Diagnosed 2012 - Asociación ELA Argentina

    Roxana Canova, Diagnosed 2012 – Asociación ELA Argentina

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013, Belgium

    Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013, Belgium

  • Margreth Burger-Saile, Diagnosed 2011 - ALS Schweiz, Switzerland

    Margreth Burger-Saile, Diagnosed 2011 – ALS Schweiz, Switzerland

  • Fabio Correia

    Fabio Correia

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Maurice LeClerc, ALS Canada

    Maurice LeClerc, ALS Canada

  • Denis Blais, Diagnosed 2015 - ALS Canada

    Denis Blais, Diagnosed 2015 – ALS Canada

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Inta Grubb, Diagnosed 2014 - MND Australia

    Inta Grubb, Diagnosed 2014 – MND Australia

  • Wilfried Leusing, Diagnosed 2010 - DGM, Germany

    Wilfried Leusing, Diagnosed 2010 – DGM, Germany

  • Jeff Sutherland

    Jeff Sutherland
    jspic

  • Dorette Lüdi, Diagnosed 2014 - ALS Schweiz, Switzerland

    Dorette Lüdi, Diagnosed 2014 – ALS Schweiz, Switzerland

  • Steven Spencer, Diagnosed 2014 - MND New Zealand

    Steven Spencer, Diagnosed 2014 – MND New Zealand

  • Ann Nicol

    Ann Nicol

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Josée Kolijn-de Man, Diagnosed 2015 - ALS Patients Connected, The Netherlands

    Josée Kolijn-de Man, Diagnosed 2015 – ALS Patients Connected, The Netherlands

Learn more about the March of Faces

Latest Tweets

  • Just now

Subscribe to our Bi-Monthly Newsletter

Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

Footer

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2023 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login